πŸ‡ΊπŸ‡Έ FDA
Patent

US 7485664

Inhibitors of TACE

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7485664 (Inhibitors of TACE) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/02, A61P1/04, A61P11/00, A61P11/06